Slovenian Krka Posts Lower Profit in First Six Months
Novo Mesto, 30 August - The Novo mesto pharma Krka recorded lower net profit in the first semester year on year, namely of SIT 4.7bn (EUR 20.6m), down 8.3%. The company's sales revenues, on the other hand, amounted to SIT 40.88bn (EUR 179,5m), up 11.4 percent over the same period last year, said Krka's press release.
The rest of this news item is available to subscribers.
The news item consists of 640 characters (without spaces) or 136 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.